Baillie Gifford & CO Procept Bio Robotics Corp Transaction History
Baillie Gifford & CO
- $111 Billion
- Q1 2025
A detailed history of Baillie Gifford & CO transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 313,884 shares of PRCT stock, worth $18.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
313,884Holding current value
$18.2 Million% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
300Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$203 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$125 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$82.2 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$69 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.59B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...